Allergan Swoops in and Bags Troubled Repros Therapeutics Post author:Sam Post published:December 11, 2017 Post category:BioPharma The deal is expected to close in the first quarter of 2018. Source: BioSpace You Might Also Like Meet This Largely Over-Looked Phase 3 Alzheimer's Company January 30, 2017 Poxel Reports Results For The First Half 2017 And Provides Corporate Update September 20, 2017 Why Pfizer's 2017 Was Mediocre at Best December 12, 2017
